A synergistic effect of HDACi and PARPi has been observed in certain cancer types.[32, 33] Previous studies have focused on the ability of combined treatments for promoting neoantigen generation, activating the cGAS–STING pathway, and/or restoring synthetic lethality. The gene discussed is CGAS; the disease is cancer.